Drug-eluting coronary stents--promise and uncertainty

Millions of patients with coronary artery disease worldwide have received coronary-artery stents, and the enormous health benefits of this technology are not in dispute. Still, when a potentially serious albeit uncommon complication such as stent thrombosis is detected, it is mandatory that everythi...

Full description

Saved in:
Bibliographic Details
Published inThe New England journal of medicine Vol. 356; no. 10; pp. 1059 - 1060
Main Authors Curfman, Gregory D, Morrissey, Stephen, Jarcho, John A, Drazen, Jeffrey M
Format Journal Article
LanguageEnglish
Published United States Massachusetts Medical Society 08.03.2007
Subjects
Circulatory system
Coronary Disease - therapy
Coronary Thrombosis - etiology
Device Approval
Drug Delivery Systems
Humans
Platelet Aggregation Inhibitors - therapeutic use
Prosthesis Design
Stents
Stents - adverse effects
Women
Online AccessGet full text

Cover

More Information
Summary:Millions of patients with coronary artery disease worldwide have received coronary-artery stents, and the enormous health benefits of this technology are not in dispute. Still, when a potentially serious albeit uncommon complication such as stent thrombosis is detected, it is mandatory that everything possible be done to aggressively examine the complication, assess the risk, understand the pathophysiological characteristics, and develop preventive measures.
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJMe068306